BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37582871)

  • 1. Identification of Significant RNA-Binding Proteins in the Process of CD44 Splicing Using the Boosted Beta Regression Algorithm.
    Novosad VO
    Dokl Biochem Biophys; 2023 Jun; 510(1):99-103. PubMed ID: 37582871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44.
    Chen Q; Gu M; Cai ZK; Zhao H; Sun SC; Liu C; Zhan M; Chen YB; Wang Z
    Cell Mol Life Sci; 2021 Feb; 78(3):949-962. PubMed ID: 32440711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNA-Binding Proteins OAS1, ZFP36L2, and DHX58 Are Involved in the Regulation of CD44 mRNA Splicing in Colorectal Cancer Cells.
    Novosad VO; Maltseva DV
    Bull Exp Biol Med; 2023 May; 175(1):144-149. PubMed ID: 37336810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition.
    Reinke LM; Xu Y; Cheng C
    J Biol Chem; 2012 Oct; 287(43):36435-42. PubMed ID: 22961986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.
    Muys BR; Anastasakis DG; Claypool D; Pongor L; Li XL; Grammatikakis I; Liu M; Wang X; Prasanth KV; Aladjem MI; Lal A; Hafner M
    Genes Dev; 2021 Jan; 35(1-2):102-116. PubMed ID: 33334821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition.
    Biddle A; Gammon L; Fazil B; Mackenzie IC
    PLoS One; 2013; 8(2):e57314. PubMed ID: 23437366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
    Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β.
    Tripathi V; Sixt KM; Gao S; Xu X; Huang J; Weigert R; Zhou M; Zhang YE
    Mol Cell; 2016 Nov; 64(3):549-564. PubMed ID: 27746021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of alternative splicing of CD44 in cancer.
    Prochazka L; Tesarik R; Turanek J
    Cell Signal; 2014 Oct; 26(10):2234-9. PubMed ID: 25025570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
    Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
    Elife; 2018 Jul; 7():. PubMed ID: 30059005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of
    Sakuma K; Sasaki E; Kimura K; Komori K; Shimizu Y; Yatabe Y; Aoki M
    Gut; 2018 Jun; 67(6):1103-1111. PubMed ID: 28360095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
    Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
    Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.
    Warzecha CC; Sato TK; Nabet B; Hogenesch JB; Carstens RP
    Mol Cell; 2009 Mar; 33(5):591-601. PubMed ID: 19285943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 Isoforms in Tumor Samples and Cell Lines of Human Colorectal Cancer.
    Novosad VO; Polikanova IS; Tonevitsky EA; Maltseva DV
    Bull Exp Biol Med; 2022 May; 173(1):155-159. PubMed ID: 35618971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress-induced alternative splicing of transformer 2beta (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells.
    Takeo K; Kawai T; Nishida K; Masuda K; Teshima-Kondo S; Tanahashi T; Rokutan K
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C330-8. PubMed ID: 19439532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression.
    Brown RL; Reinke LM; Damerow MS; Perez D; Chodosh LA; Yang J; Cheng C
    J Clin Invest; 2011 Mar; 121(3):1064-74. PubMed ID: 21393860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis.
    Primeaux M; Gowrikumar S; Dhawan P
    Clin Exp Metastasis; 2022 Jun; 39(3):391-406. PubMed ID: 35023031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP.
    Horiguchi K; Sakamoto K; Koinuma D; Semba K; Inoue A; Inoue S; Fujii H; Yamaguchi A; Miyazawa K; Miyazono K; Saitoh M
    Oncogene; 2012 Jun; 31(26):3190-201. PubMed ID: 22037216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.